Variant report

Variant	esv1827139
Chromosome Location	chr19:41348820-41395889
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:419)
CpG islands
(count:732)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:419 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
2	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
3	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
4	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
5	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
6	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
7	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
8	CBX3	chr19:41349182-41350047	K562	blood:	n/a	n/a
9	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
10	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
11	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
12	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
13	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
14	CEBPB	chr19:41378139-41378466	K562	blood:	n/a	n/a
15	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
16	CEBPB	chr19:41370305-41370801	K562	blood:	n/a	chr19:41370433-41370441
17	CEBPB	chr19:41368480-41368982	A549	lung:	n/a	n/a
18	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
19	CEBPB	chr19:41378202-41378474	K562	blood:	n/a	n/a
20	CEBPB	chr19:41374056-41374100	A549	lung:	n/a	n/a
21	CEBPB	chr19:41373834-41374300	A549	lung:	n/a	n/a
22	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
23	CEBPB	chr19:41373920-41374208	K562	blood:	n/a	n/a
24	CEBPB	chr19:41370543-41370910	K562	blood:	n/a	n/a
25	CEBPB	chr19:41370209-41371189	K562	blood:	n/a	chr19:41370433-41370441
26	CEBPD	chr19:41370661-41370862	K562	blood:	n/a	n/a
27	CEBPD	chr19:41370295-41371143	K562	blood:	n/a	n/a
28	CEBPD	chr19:41392214-41392550	K562	blood:	n/a	n/a
29	CEBPZ	chr19:41395862-41395912	HepG2	liver:	n/a	n/a
30	CTCF	chr19:41368140-41368290	NHDF-neo	bronchial:	n/a	n/a
31	CTCF	chr19:41354580-41354730	GM12871	blood:	n/a	chr19:41354699-41354709
32	CTCF	chr19:41368660-41368810	A549	lung:	n/a	n/a
33	CTCF	chr19:41354540-41354690	HCM	heart:	n/a	n/a
34	CTCF	chr19:41368340-41368490	NHDF-neo	bronchial:	n/a	n/a
35	CTCF	chr19:41354359-41354806	A549	lung:	n/a	chr19:41354699-41354709
36	CTCF	chr19:41354580-41354730	HVMF	connective:	n/a	chr19:41354699-41354709
37	CTCF	chr19:41364147-41364298	K562	blood:	n/a	n/a
38	CTCF	chr19:41360494-41360547	Kidney_OC	kidney:	n/a	n/a
39	CTCF	chr19:41354302-41354800	A549	lung:	n/a	chr19:41354699-41354709
40	CTCF	chr19:41368260-41368410	HFF	foreskin:	n/a	n/a
41	CTCF	chr19:41368260-41368410	HVMF	connective:	n/a	n/a
42	CTCF	chr19:41354520-41354670	HUVEC	blood vessel:	n/a	n/a
43	CTCF	chr19:41354488-41354703	IMR90	lung:	n/a	n/a
44	CTCF	chr19:41386434-41386449	K562	blood:	n/a	n/a
45	CTCF	chr19:41381740-41381820	GM13976	blood:	n/a	n/a
46	CTCF	chr19:41354802-41355008	Lung_OC	lung:	n/a	n/a
47	CTCF	chr19:41364190-41364227	MCF-7	breast:	n/a	n/a
48	CTCF	chr19:41386211-41386665	K562	blood:	n/a	n/a
49	CTCF	chr19:41368540-41368690	AoAF	blood vessel:	n/a	n/a
50	CTCF	chr19:41368360-41368510	K562	blood:	n/a	n/a

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41386441-41386491	IMR90	lung:	fetal
2	chr19:41386507-41386557	AG09319	gingival:	n/a
3	chr19:41388384-41388434	HIPEpiC	eye:	n/a
4	chr19:41386507-41386557	HCPEpiC	choroid plexus:	n/a
5	chr19:41389684-41389734	Jurkat	blood:	n/a
6	chr19:41388384-41388434	NHBE	bronchial:	n/a
7	chr19:41354682-41354732	T-47D	breast:	n/a
8	chr19:41354682-41354732	HCF	heart:	n/a
9	chr19:41383654-41383704	H1-hESC	embryonic stem cell:	embryo
10	chr19:41386441-41386491	NB4	blood:	n/a
11	chr19:41388232-41388282	PrEC	prostate:	n/a
12	chr19:41354553-41354603	HepG2	liver:	n/a
13	chr19:41386441-41386491	HCF	heart:	n/a
14	chr19:41386507-41386557	HCF	heart:	n/a
15	chr19:41386507-41386557	BE2_C	brain:	n/a
16	chr19:41354553-41354603	AG04449	skin:	fetal
17	chr19:41388232-41388282	GM12891	blood:	n/a
18	chr19:41354142-41354192	HAEpiC	amniotic membrane:	n/a
19	chr19:41354553-41354603	LNCaP	prostate:	n/a
20	chr19:41388384-41388434	ECC-1	luminal epithelium:	n/a
21	chr19:41388384-41388434	BE2_C	brain:	n/a
22	chr19:41351924-41351974	HCF	heart:	n/a
23	chr19:41386441-41386491	ovcar-3	ovarian:	n/a
24	chr19:41354142-41354192	H1-hESC	embryonic stem cell:	embryo
25	chr19:41386441-41386491	HRE	kidney:	n/a
26	chr19:41385865-41385915	AG09319	gingival:	n/a
27	chr19:41386441-41386491	HCT-116	colon:	n/a
28	chr19:41355973-41356023	HUVEC	blood vessel:	n/a
29	chr19:41354682-41354732	HepG2	liver:	n/a
30	chr19:41354553-41354603	Hepatocyte	liver:	n/a
31	chr19:41386507-41386557	PANC-1	pancreas:	n/a
32	chr19:41354553-41354603	MCF10A-Er-Src	breast:	n/a
33	chr19:41354682-41354732	HPAEpiC	pulmonary alveolar:	n/a
34	chr19:41386507-41386557	HIPEpiC	eye:	n/a
35	chr19:41386441-41386491	HMEC	breast:	n/a
36	chr19:41351924-41351974	HUVEC	blood vessel:	n/a
37	chr19:41389684-41389734	SK-N-SH	brain:	n/a
38	chr19:41383654-41383704	SK-N-SH	brain:	n/a
39	chr19:41385865-41385915	HPAEpiC	pulmonary alveolar:	n/a
40	chr19:41354142-41354192	AG04450	lung:	fetal
41	chr19:41351924-41351974	SK-N-MC	brain:	n/a
42	chr19:41383654-41383704	GM19239	blood:	n/a
43	chr19:41354553-41354603	SK-N-MC	brain:	n/a
44	chr19:41388232-41388282	HEK293	kidney:	embryo
45	chr19:41389684-41389734	ovcar-3	ovarian:	n/a
46	chr19:41383654-41383704	ovcar-3	ovarian:	n/a
47	chr19:41351924-41351974	GM12892	blood:	n/a
48	chr19:41388232-41388282	K562	blood:	n/a
49	chr19:41355973-41356023	HCPEpiC	choroid plexus:	n/a
50	chr19:41388232-41388282	GM06990	blood:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
2	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
3	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:
4	chr16:4474827..4477394-chr19:41351022..41353007,2	MCF-7	breast:

No data

Variant related genes	Relation type
CYP2G1P	TF binding region
CYP2A6	TF binding region
CYP2A7	TF binding region
CYP2G1P	CpG island
CYP2A6	CpG island
CYP2A7	CpG island
ENSG00000262246	chromatin interactions
ENSG00000103423	chromatin interactions
ENSG00000105245	chromatin interactions

Extended variants
information (count: 2596 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:2596 , 50 per page) page: 1 2 3 4 5 6 7 ... 52

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs551384469	chr19:41349016-41349017	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs28742185	chr19:41349172-41349173	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
3	rs556743951	chr19:41349197-41349198	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs2259217	chr19:41349233-41349234	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs2259218	chr19:41349238-41349239	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs2259219	chr19:41349250-41349251	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs2431412	chr19:41349259-41349260	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs183581274	chr19:41349288-41349289	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs527411800	chr19:41349319-41349320	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs377019695	chr19:41349320-41349321	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs3835001	chr19:41349324-41349325	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs72549453	chr19:41349343-41349344	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs146895354	chr19:41349351-41349352	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs546137020	chr19:41349370-41349371	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs72549452	chr19:41349371-41349372	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs72549451	chr19:41349396-41349397	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs188579992	chr19:41349398-41349399	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs138956819	chr19:41349412-41349413	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs372759837	chr19:41349436-41349437	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs569152950	chr19:41349457-41349458	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs192752442	chr19:41349472-41349473	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs28399483	chr19:41349497-41349498	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs59304147	chr19:41349502-41349503	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs558177610	chr19:41349508-41349509	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs113777046	chr19:41349517-41349518	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs111419867	chr19:41349518-41349519	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs112026263	chr19:41349519-41349520	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs374636850	chr19:41349521-41349522	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs573167674	chr19:41349533-41349534	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs8192733	chr19:41349550-41349551	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs386809285	chr19:41349597-41349598	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs28399481	chr19:41349598-41349599	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs142901606	chr19:41349601-41349602	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs386809286	chr19:41349603-41349604	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs28399479	chr19:41349605-41349606	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs28399478	chr19:41349612-41349613	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs28399477	chr19:41349618-41349619	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs28399476	chr19:41349619-41349620	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs28399475	chr19:41349620-41349621	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs28399474	chr19:41349621-41349622	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs28399473	chr19:41349626-41349627	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs562378426	chr19:41349636-41349637	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs7248240	chr19:41349640-41349641	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	mRNA abundance
44	rs28399472	chr19:41349642-41349643	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs28399471	chr19:41349644-41349645	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs28399470	chr19:41349647-41349648	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs28399469	chr19:41349651-41349652	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs560208518	chr19:41349653-41349654	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs527558515	chr19:41349661-41349662	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs139835762	chr19:41349704-41349705	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:434 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41330200-41349400	Weak transcription	Right Ventricle	heart
2	chr19:41333600-41349400	Weak transcription	Left Ventricle	heart
3	chr19:41339600-41349400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr19:41341800-41349400	Weak transcription	K562	blood
5	chr19:41347800-41349000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr19:41347800-41349800	Weak transcription	Lung	lung
7	chr19:41348800-41349000	Weak transcription	Primary T helper cells PMA-I stimulated	--
8	chr19:41348800-41349000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
9	chr19:41349000-41349200	Enhancers	Primary neutrophils fromperipheralblood	blood
10	chr19:41349000-41349200	Enhancers	Primary T helper naive cells from peripheral blood	blood
11	chr19:41349000-41349200	Enhancers	Primary T helper cells PMA-I stimulated	--
12	chr19:41349000-41349200	Enhancers	Primary T helper cells fromperipheralblood	blood
13	chr19:41349000-41349200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
14	chr19:41349000-41349200	Enhancers	Primary T killer memory cells from peripheral blood	blood
15	chr19:41349000-41349200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr19:41349000-41349200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr19:41349000-41349200	Enhancers	Duodenum Mucosa	Duodenum
18	chr19:41349000-41349400	Enhancers	Primary B cells from peripheral blood	blood
19	chr19:41349200-41349400	Enhancers	HUES48 Cell Line	embryonic stem cell
20	chr19:41349200-41349400	Enhancers	iPS-15b Cell Line	embryonic stem cell
21	chr19:41349200-41349400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
22	chr19:41349200-41349400	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr19:41349200-41349400	Enhancers	Primary T cells fromperipheralblood	blood
24	chr19:41349200-41349400	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
25	chr19:41349200-41349400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
26	chr19:41349200-41349400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
27	chr19:41349200-41349400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
28	chr19:41349200-41349400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
29	chr19:41349200-41349400	Enhancers	Fetal Intestine Large	intestine
30	chr19:41349200-41349400	Enhancers	Fetal Thymus	thymus
31	chr19:41349200-41349400	Enhancers	GM12878-XiMat	blood
32	chr19:41349200-41349400	Enhancers	Monocytes-CD14+_RO01746	blood
33	chr19:41349200-41349600	Active TSS	Primary hematopoietic stem cells	blood
34	chr19:41349200-41349600	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
35	chr19:41349200-41349600	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
36	chr19:41349200-41349600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr19:41349200-41349600	Flanking Active TSS	Duodenum Mucosa	Duodenum
38	chr19:41349200-41349600	Enhancers	Esophagus	oesophagus
39	chr19:41349200-41349600	Enhancers	Placenta	Placenta
40	chr19:41349200-41349600	Enhancers	Small Intestine	intestine
41	chr19:41349200-41349800	Active TSS	Breast Myoepithelial Primary Cells	Breast
42	chr19:41349200-41349800	Enhancers	Primary hematopoietic stem cells short term culture	blood
43	chr19:41349200-41349800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
44	chr19:41349200-41349800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr19:41349200-41350000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
46	chr19:41349200-41350000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
47	chr19:41349200-41350200	Active TSS	HUES64 Cell Line	embryonic stem cell
48	chr19:41349200-41350200	Active TSS	Primary B cells from cord blood	blood
49	chr19:41349200-41350200	Enhancers	Primary T cells from cord blood	blood
50	chr19:41349200-41350400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links